Bigelow Investment Advisors LLC Increases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bigelow Investment Advisors LLC raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 73.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,053 shares of the financial services provider’s stock after purchasing an additional 1,722 shares during the quarter. Bigelow Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $551,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Vontobel Holding Ltd. grew its holdings in iShares Biotechnology ETF by 9.5% during the 1st quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock valued at $659,000 after purchasing an additional 440 shares in the last quarter. Blair William & Co. IL increased its position in shares of iShares Biotechnology ETF by 9.7% during the first quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock worth $2,439,000 after acquiring an additional 1,659 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in iShares Biotechnology ETF by 11.7% in the first quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock valued at $1,796,000 after purchasing an additional 1,445 shares during the last quarter. DCF Advisers LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter valued at approximately $912,000. Finally, Laurel Wealth Advisors Inc. increased its holdings in iShares Biotechnology ETF by 22.6% during the 1st quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock worth $393,000 after purchasing an additional 557 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB traded up $0.08 during midday trading on Friday, hitting $124.72. The company had a trading volume of 1,996,612 shares, compared to its average volume of 1,809,704. The company’s 50 day moving average price is $135.29 and its 200 day moving average price is $129.51. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.